Marinus Pharmaceuticals reported $78.49M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Adamas Pharmaceuticals ADMS:US -21606000 17.57M
ALKERMES ALKS:US $ 1096.17M 1.73M
Amgen AMGN:US $ 8217M 30M
Aptinyx Inc APTX:US $ 112.04M 18.71M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Biogen BIIB:US $ 10429.9M 322M
Eisai 4523:JP Y 730336M 7784M
Enanta Pharmaceuticals ENTA:US $ 399.43M 18.42M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Gilead Sciences GILD:US $ 21471M 1768M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Intra Cellular Therapies ITCI:US $ 486.76M 66.83M
Marinus Pharmaceuticals MRNS:US $ 78.49M 16.57M
Minerva Neurosciences NERV:US $ 28.08M 8.09M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Supernus Pharmaceuticals SUPN:US $ 810.47M 24.89M
Vertex Pharmaceuticals VRTX:US $ 9530.71M 334.31M
YTE INCY:US $ 3148.66M 212.8M
Zogenix ZGNX:US $ 224.3M 48.56M